Lucira Health to Announce First Quarter 2022 Financial Results
April 28 2022 - 7:00AM
Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical
technology company focused on the development and commercialization
of transformative and innovative infectious disease test kits,
today announced that the company will report first quarter 2022
financial results on Thursday, May 12, 2022. Lucira’s management
will host a conference call and webcast at 1:30 p.m. PT / 4:30 p.m.
ET that day to discuss the financial results and provide a
corporate update.
Conference Call and Webcast DetailsThe
conference call can be accessed by dialing (833) 562-0151 for
participants in the U.S. or Canada and (661) 567-1232 for
international callers, using conference ID 1052178. A live and
archived webcast of the event can be accessed through the following
link ir.lucirahealth.com.
About Lucira HealthLucira is a medical
technology company focused on the development and commercialization
of transformative and innovative infectious disease tests. Lucira's
testing platform produces lab quality molecular testing in a
single-use, consumer-friendly, palm-size test kit powered by two AA
batteries. Lucira designed its test kits to provide accurate,
reliable, and on-the-spot molecular test results anywhere and at
any time.
Lucira tests are used by leading businesses and healthcare
organizations like Salesforce, Amazon, Air Canada, Cleveland
Clinic, Sutter Health and many more. Beyond its COVID-19 tests,
Lucira is working on new diagnostic tests including a single test
for COVID-19 & Flu as well as other infectious diseases. For
more information, visit www.lucirahealth.com.
Investor ContactGreg
ChodaczekInvestorrelations@lucirahealth.com332-895-3230
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Sep 2023 to Sep 2024